The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Are The Forecasted Market Size Figures For The Rapid Diagnostics Market In 2026 And 2030?
The rapid diagnostics market has experienced significant expansion recently. Forecasts indicate it will expand from $36.08 billion in 2025 to $40.66 billion by 2026, achieving a compound annual growth rate (CAGR) of 12.7%. Historically, this growth has been driven by factors such as the escalating demand for expedited clinical diagnostics, the proliferation of decentralized healthcare environments, an increase in the incidence of chronic and infectious ailments, enhanced availability of diagnostic instruments, and the expansion of outpatient diagnostic provisions.
The rapid diagnostics market is projected for substantial expansion over the coming years, reaching $64.79 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 12.4%. This projected increase during the forecast period is driven by several factors, including heightened investments in molecular diagnostics, the increasing uptake of connected diagnostic devices, the broadening availability of home-based testing solutions, a stronger emphasis on personalized diagnostics, and the expanded application of data-driven clinical workflows. Key developments anticipated in this period encompass the wider utilization of point-of-care diagnostic platforms, a rise in the adoption of molecular rapid testing, the increasing integration of digital interpretation for results, the proliferation of portable diagnostic instruments, and a heightened commitment to providing early clinical decision support.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24679&type=smp
What Are The Main Drivers Accelerating The Growth Of The Rapid Diagnostics Market?
The expanding occurrence of infectious diseases is anticipated to fuel the expansion of the rapid diagnostics market in the future. These diseases are health conditions resulting from disease-causing microorganisms like bacteria, viruses, parasites, or fungi, capable of transmitting directly or indirectly between individuals. A key factor behind the growing incidence of infectious diseases is the rise in global travel, which facilitates quicker spread and higher rates of infection. Rapid diagnostic tools are crucial in combating these diseases by allowing for swift and precise identification of pathogens, thereby enabling prompt treatment choices, decreasing transmission, and enhancing patient recovery. For instance, in May 2025, as reported by The World Health Organization (WHO), a Switzerland-based specialized agency of the United Nations focused on international public health, global SARS-CoV-2 (the virus responsible for causing COVID-19, an infectious disease) activity has been increasing since mid-February 2025, based on sentinel site data, with the test positivity rate reaching 11%, a level last seen in July 2024. Consequently, the rising prevalence of infectious disease is propelling the rapid diagnostics market.
How Is The Rapid Diagnostics Market Examined Through Segment Analysis?
The rapid diagnostics market covered in this report is segmented –
1) By Product Type: Kits, Reagents, Instruments, Other Product Types
2) By Platform: Immunoassays, Molecular Detection, Other Rapid Diagnostic Platforms
3) By Application: Blood Glucose Testing, Infectious Disease Testing, Cardiometabolic Testing, Pregnancy and Fertility Testing, Fecal Occult Blood Testing, Coagulation Testing, Toxicology Testing
4) By Distribution Channel: Hospital Pharmacies, Brick and Mortar, E-Commerce, Other Distribution Channels
5) By End Use: Diagnostic Centers, Homecare Settings, Hospital Pharmacies, Other End Users
Subsegments:
1) By Kits: Lateral Flow Assay Kits, PCR Kits, Immunoassay Kits, Microfluidic Kits, Molecular Diagnostic Kits, Multiplex Kits
2) By Reagents: Enzymes, Buffers, Probes and Primers, Stains and Dyes, Antibodies, Calibration and Control Reagents
3) By Instruments: PCR Machines, Lateral Flow Readers, Immunoassay Analyzers, Microfluidic Analyzers, Automated Sample Processors, Biosensors
4) By Other Product Types: Software and Data Management Tools, Sample Collection Devices, Accessories and Consumables, Calibration Standards, Point-of-Care Devices
Which Trends Are Influencing The Direction Of The Rapid Diagnostics Market?
Major companies operating in the rapid diagnostic test kits market are focusing on developing novel solutions, such as saliva-based pregnancy test kits, to gain a competitive edge in the market. Saliva-based pregnancy test kits are diagnostic tools designed to detect pregnancy by analyzing a woman’s saliva for the presence of hormonal changes, particularly human chorionic gonadotropin (hCG), which is produced during pregnancy. For instance, in February 2023, Abingdon Health plc, a UK-based, near-patient diagnostics company, launched Salistick, the first rapid saliva-based pregnancy test in the UK and Ireland, marking a significant innovation in home pregnancy testing by offering a cleaner, more convenient alternative to traditional urine-based tests. This highly accurate test detects the pregnancy hormone β-hCG in saliva, allowing women to perform early pregnancy detection anywhere and anytime, while also enabling a more personal and shareable testing experience.
Which Industry Players Are Present In The Rapid Diagnostics Market?
Major companies operating in the rapid diagnostics market are Johnson And Johnson Services Inc, F Hoffmann La Roche Ltd, Thermo Fisher Scientific Inc, Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson And Company, Hologic Inc, bioMerieux SA, QuidelOrtho Corporation, Bio Rad Laboratories Inc, QIAGEN NV, Cepheid Inc, OraSure Technologies Inc, Nova Biomedical Corporation, Fujirebio Holdings Inc, Sekisui Diagnostics LLC, EKF Diagnostics Holdings plc, Trinity Biotech plc, Abingdon Health plc, Abionic SA, LumiraDx Ltd
Access The Complete Rapid Diagnostics Market Report:
https://www.thebusinessresearchcompany.com/report/rapid-diagnostics-global-market-report
Which Region Commands The Largest Share Of The Rapid Diagnostics Market?
North America was the largest region in the rapid diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the rapid diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Rapid Diagnostics Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/customise?id=24679&type=smp
Browse Through More Reports Similar to the Global Rapid Diagnostics Market 2026, By The Business Research Company
Lateral Flow Immunoassay Based Rapid Test Global Market Report 2026
Covid 19 Rapid Test Kits Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/covid-19-rapid-test-kits-global-market-report
Rapid Strength Concrete Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/rapid-strength-concrete-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
